VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GMAB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GMABGenmab A/S
$28.01$17.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGMABPrice History

GMAB logoGenmab A/S (GMAB) Stock Price History

Historical prices from 2009 to 2026

$28.01-0.50  (-1.77%)close Jul 6
Returns
1M
+12.9%
3M
+0.9%
YTD
-12.0%
1Y
+36.5%
3Y
-9.9%
5Y
-7.8%
ATH$103.19May 2018-72.9%
ATL$0.65Jul 2012pre-split
Avg Vol (50D)1.8M/ day
52-Week Range$20.33 — $35.43
LowCurrent: $28.01High

Loading 10-year price history...

GMAB Historical Performance

1 YearTotal Return
+36.5%
Price: +36.5%
3 YearsTotal Return
-26.8%
CAGR: -9.9%
Price: -26.8%
5 YearsTotal Return
-33.3%
CAGR: -7.8%
Price: -33.3%
YTD
-12.0%

GMAB Annual Returns

Year-by-year price performance · 2009–2026

Best+179.3%2013
Worst-59.9%2009
Up years9/18
2009-59.9%
2010-19.2%
2011-51.6%
2012+114.1%
2013+179.3%
2014+47.6%
2015+121.9%
2016+23.3%
2017-3.5%
2018-3.9%
2019+43.0%
2020+82.3%
2021-2.9%
2022+6.8%
2023-26.0%
2024-35.0%
2025+46.7%
2026-7.5%
2009 annual price return
-59.9%
2010 annual price return
-19.2%
2011 annual price return
-51.6%
2012 annual price return
+114.1%
2013 annual price return
+179.3%
2014 annual price return
+47.6%
2015 annual price return
+121.9%
2016 annual price return
+23.3%
2017 annual price return
-3.5%
2018 annual price return
-3.9%
2019 annual price return
+43.0%
2020 annual price return
+82.3%
2021 annual price return
-2.9%
2022 annual price return
+6.8%
2023 annual price return
-26.0%
2024 annual price return
-35.0%
2025 annual price return
+46.7%
2026 annual price return
-7.5%
LessMore
Alpha vs S&P 500
1Y+3.9%
3Y-31.6%
5Y-20.6%

Price returns only.

Download Historical Data

4,301 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

GMAB Stock Price Trajectory (2009–2026)

As of July 7, 2026, Genmab A/S (GMAB) trades at $28.01, representing a +36.5% return over the past year. The stock has delivered a -33.3% total return over five years (-7.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $103.19 on May 1, 2018. From this peak, GMAB has corrected -72.9%, currently trading 4% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers REGN (+20.8% 1Y), SRPT (+10.7% 1Y), and INCY (+71.9% 1Y), GMAB has underperformed the peer group average. Compare GMAB vs REGN →

GMAB Historical Price Data · from 2009

Rows 1–50 of 4,301
Date Open High Low Close Volume Change %
2026-07-0628.1328.3427.6428.011.78M-1.77%
2026-07-0228.1528.7828.0728.521.41M+3.17%
2026-07-0127.9228.0027.3327.641.44M+0.62%
2026-06-3027.9628.1827.3427.472.56M+5.57%
2026-06-2926.2326.4225.9926.02497K-0.38%
2026-06-2625.4326.1625.3426.120-0.08%
2026-06-2525.8926.3725.8826.141.28M+1.06%
2026-06-2426.0726.2425.8025.861.36M-0.29%
2026-06-2325.9226.1825.8425.941.22M+1.29%
2026-06-2225.0525.6624.8825.611.57M+1.35%
2026-06-1825.6825.7325.0025.271.81M-0.47%
2026-06-1724.9525.7724.8725.392.44M+2.63%
2026-06-1624.4924.7724.0924.742.19M+0.65%
2026-06-1525.1425.2024.5224.581.02M-1.99%
2026-06-1225.0725.2624.9325.081.11M-0.63%
2026-06-1125.0025.3924.8025.241.17M+3.06%
2026-06-1024.7925.1424.4524.49870K-2.43%
2026-06-0924.8725.1624.7025.101.32M+1.21%
2026-06-0825.1525.2224.5824.801.42M-1.39%
2026-06-0524.6625.2924.6625.152.08M+1.70%
2026-06-0424.4424.8224.3424.731.23M+3.56%
2026-06-0323.6823.9123.6223.881.37M+0.13%
2026-06-0224.1824.2523.7723.853.60M-6.29%
2026-06-0125.7825.9325.3925.451.71M-3.34%
2026-05-2926.9727.0726.3326.332.15M-2.63%
2026-05-2826.2727.1426.2127.042.32M+1.24%
2026-05-2726.7926.9726.6026.71761K-0.67%
2026-05-2626.9327.1326.6226.891.02M+0.07%
2026-05-2226.8627.0226.6726.871.20M-0.67%
2026-05-2126.8827.2026.6327.051.04M-0.59%
2026-05-2026.1627.3626.0927.215.20M+5.96%
2026-05-1925.6925.9825.5225.684.33M-2.62%
2026-05-1826.5426.6026.1426.372.85M-0.64%
2026-05-1526.8426.9626.4426.541.35M-1.34%
2026-05-1426.8227.1626.1826.901.52M+1.32%
2026-05-1326.5326.7726.3426.551.97M-1.99%
2026-05-1226.4227.2326.4227.092.24M+3.48%
2026-05-1126.0026.6125.9226.182.64M-0.98%
2026-05-0825.5626.7625.3426.445.92M-2.29%
2026-05-0728.2128.2826.8027.063.49M-2.98%
2026-05-0627.5828.0027.5027.891.45M+1.28%
2026-05-0527.5027.6127.0027.54657K+1.84%
2026-05-0426.2527.0926.2427.041.19M+2.23%
2026-05-0126.5526.7326.3326.45714K-0.26%
2026-04-3026.4626.6926.3926.521.23M+1.57%
2026-04-2926.0326.2925.7226.111.83M-2.54%
2026-04-2826.4627.2826.3626.791.39M+0.56%
2026-04-2726.6627.0626.6126.64844K-0.86%
2026-04-2426.9727.1126.8126.871.09M-0.41%
2026-04-2327.4927.5726.8126.981.04M-2.56%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GMAB — Frequently Asked Questions

Quick answers to the most common questions about buying GMAB stock.

How has GMAB stock performed recently?

GMAB returned +36.5% over the past year, beating its 5-year annualized CAGR of -7.8%. The stock trades below its 200-day moving average, confirming the uptrend.

What is GMAB's all-time high price?

Genmab A/S reached $103.19 on 2018-05-01. The 52-week high is $35.43. Current 1-year return of +36.5% places the stock closer to historical peaks.

Where can I download GMAB historical price data?

This page provides GMAB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2009-2026, downloadable in CSV format.

479 data points · sampled from 4,301